< Back to scientific publications

Magazine 2.4

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Authors: lionetti R

Date: May 2019

Scope of interest: infectious/hepatological




You may also be interested in:

Magazine

AntiemeticProphylaxis with NEPA (NETUPITANT/PALONOSETRON) and Dexamethasone to PreventChemotherapy-Induced Nausea and Vomiting (CINV) in Hodgkin’SLymphoma Naïve PatientsReceiving ABVD Regimen: A MulticenterPhaseIia Study

Authors: Daniela Nasso,Silvia Bolis, Elisabetta Abbruzzese, Ilaria Romano,Ida Provenzano Cristiano Tesei,Ida Provenzano, Maria Cantonetti

Date: 2020

Scope of interest: Haematology


Read details
Magazine 3.25

Social isolation risk factors in older hospitalized individuals.

Authors: Giuli C, Smoke Scavenger L, Sirolla C, Abbatecola AM, Lattanzio F, Postacchini D

Date: 2012

Scope of interest: ageing


Read details
Report/Poster of Convention/Congress Act

22q11.2 deletion and epilepsy: syndromic contexts and neurophysiological aspects

Authors: M. Fanella, A. Morano, J. Fattouch, S. Casciato, M. Albini, L.M. Basili, M. Frascarelli, T. Accinni, A. Buzzanca, A.T. Giallonardo, M. Biondi, F. Di Fabio, C. Di Bonaventura

Date: 2018

Scope of interest: Rare diseases/epilepsy


Read details